Lake Bleu Capital - aVenture Asset Manager Research
Lake Bleu Capital
Operating Status: Operating
Lake Bleu Capital: A Hong Kong-based healthcare-focused investment platform.
Location
Rhode Island, US
Founded
2020
Lake Bleu Capital is a Hong Kong-based investment firm specializing in the healthcare sector. The firm typically invests in later-stage rounds, including Series B, Series C, and private equity rounds. Their investment focus is on innovative healthcare companies that have the potential to make significant impacts in their fields.
Notable portfolio companies include AffaMed Therapeutics, Brii Biosciences, Insilico Medicine, and MicroPort CardioFlow, which have collectively raised substantial funding. Lake Bleu Capital is known for its deep industry expertise and strategic support, providing value-add services that go beyond capital investment to help portfolio companies achieve their growth objectives.
Lake Bleu Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count5
Top Investment Stages
Series C2 (50.0%)
Series B1 (25.0%)
Series E1 (25.0%)
Stage Mix
Series C 50%Series B 25%Series E 25%
Concentration shown as share of disclosed investments by stage.